Akso Health Group
AHG
$1.57
-$0.02-1.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -12.88% | -12.88% | 0.93% | 0.93% | 415.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.88% | -12.88% | 0.93% | 0.93% | 415.75% |
| Cost of Revenue | -10.22% | -10.22% | -5.42% | -5.42% | 478.67% |
| Gross Profit | -33.74% | -33.74% | 223.03% | 223.03% | -668.59% |
| SG&A Expenses | -33.68% | -33.68% | 180.91% | 180.91% | -54.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.30% | -16.30% | 12.86% | 12.86% | 43.13% |
| Operating Income | 24.23% | 24.23% | -165.79% | -165.79% | 46.50% |
| Income Before Tax | 88.38% | 88.38% | -180.16% | -180.16% | -2,638.33% |
| Income Tax Expenses | 94.00% | 94.00% | -456.41% | -456.41% | -15,420,100.00% |
| Earnings from Continuing Operations | 87.09% | 87.09% | -135.35% | -135.35% | -2,128.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -96.35% | -96.35% | 174.56% | 174.56% | 800.00% |
| Net Income | 87.06% | 87.06% | -117.49% | -117.49% | -2,139.40% |
| EBIT | 24.23% | 24.23% | -165.79% | -165.79% | 46.50% |
| EBITDA | -13.30% | -13.30% | 59.34% | 59.34% | -- |
| EPS Basic | 91.63% | 91.63% | 8.33% | 8.33% | -190.00% |
| Normalized Basic EPS | 35.71% | 35.71% | 0.00% | 0.00% | 94.64% |
| EPS Diluted | 90.61% | 90.61% | -25.00% | -25.00% | -156.76% |
| Normalized Diluted EPS | 35.71% | 35.71% | 0.00% | 0.00% | 94.64% |
| Average Basic Shares Outstanding | 55.17% | 55.17% | 145.56% | 145.56% | 672.07% |
| Average Diluted Shares Outstanding | 55.17% | 55.17% | 145.56% | 145.56% | 672.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |